SLS
NASDAQ HealthcareSELLAS Life Sciences Group, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $5.03 |
|---|---|
| Volume | 8,342,612 |
| Market Cap | 856.52M |
| Beta | 2.210 |
| RSI (14-Day) | 62.1 |
| 200-Day MA | $2.44 |
| 50-Day MA | $4.32 |
| 52-Week High | $6.14 |
| 52-Week Low | $0.95 |
| Forward P/E | -15.88 |
| Price / Book | 13.78 |
🎯 Investment Strategy Scores
How SLS scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
4/100
High dividend yield + low volatility
🚀 Moon Shot
86/100
High growth potential (high beta + oversold)
🔪 Falling Knife
2/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
88/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
23/100
Large-cap, institutional-quality stocks
Find SLS in your text
Paste any text on the homepage — the tool will extract SLS and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.